HUS1 and ovarian cancer: Contrarily, antisense oligonucleotides that inhibit HUS1 increase the sensitivity of human lung carcinoma cells to the chemotherapy drug cisplatin, and high HUS1 expression is significantly associated with unfavorable clinicopathologic indicators in ovarian cancer.